|
Warding off resistance to Gleevec therapy. (Combinations Tested).(imatinib mesylate)
Publication: Internal Medicine News Publication Date: 15-FEB-02 Author: DeMott, Kathryn
|
|
|
|
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
|
|
|
COPYRIGHT 2002 International Medical News Group
ORLANDO, FLA. -- The development of resistance to imatinib mesylate (Gleevec) is expected to be just a matter of time, a conjecture that has investigators prowling for agents to act synergistically and ward off resistance to the cancer drug.
Of chronic myeloid leukemia patients who have failed interferon-c therapy,...
Read the full article for free courtesy of your local library.
|
|
|
|
 |
| More Articles from Internal Medicine News |
Will vitamin C reduce the duration of a cold? (Mindful Practice).
February 15, 2002
|
Adjuvant bisphosphonate reduces bone metastases. (In Breast Cancer Pat...
February 15, 2002
|
Breast cancer chemo linked to leukemia. ('Alarming' New Finding).(doxo...
February 15, 2002
|
Bioelectric study limits unneeded breast biopsies. (Palpable, Suspicio...
February 15, 2002
|
Cryotherapy an alternative to surgery for breast fibroadenomas. (Regro...
February 15, 2002
|
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
